Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia

Céline Callens(Université Paris Sciences et Lettres), Olivier Hermine(Centre National de la Recherche Scientifique)
The Journal of Experimental Medicine
April 5, 2010
10.1084/jem.20091488
Cited by 194

Related Papers

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2017|736
Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
|Blood|1996|417
Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
|Blood|1996|411
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
|PLoS ONE|2009|409
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
|The Lancet|2016|401